• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白寡聚体在帕金森病中的作用。

The Role of α-Synuclein Oligomers in Parkinson's Disease.

机构信息

National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Haidian District, Beijing 100190, China.

School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

Int J Mol Sci. 2020 Nov 17;21(22):8645. doi: 10.3390/ijms21228645.

DOI:10.3390/ijms21228645
PMID:33212758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7697105/
Abstract

α-synuclein (α-syn) is a protein associated with the pathogenesis of Parkinson's disease (PD), the second most common neurodegeneration disease with no effective treatment. However, how α-syn drives the pathology of PD remains elusive. Recent studies suggest that α-syn oligomers are the primary cause of neurotoxicity and play a critical role in PD. In this review, we discuss the process of α-syn oligomers formation and the current understanding of the structures of oligomers. We also describe seed and propagation effects of oligomeric forms of α-syn. Then, we summarize the mechanism by which α-syn oligomers exert neurotoxicity and promote neurodegeneration, including mitochondrial dysfunction, endoplasmic reticulum stress, proteostasis dysregulation, synaptic impairment, cell apoptosis and neuroinflammation. Finally, we investigate treatment regimens targeting α-syn oligomers at present. Further research is needed to understand the structure and toxicity mechanism of different types of oligomers, so as to provide theoretical basis for the treatment of PD.

摘要

α-突触核蛋白(α-syn)是与帕金森病(PD)发病机制相关的一种蛋白质,PD 是第二常见的神经退行性疾病,目前尚无有效的治疗方法。然而,α-syn 如何驱动 PD 的发病机制仍不清楚。最近的研究表明,α-syn 寡聚体是神经毒性的主要原因,并在 PD 中发挥关键作用。在这篇综述中,我们讨论了 α-syn 寡聚体形成的过程以及目前对寡聚体结构的理解。我们还描述了 α-syn 寡聚体的种子和传播效应。然后,我们总结了 α-syn 寡聚体发挥神经毒性和促进神经退行性变的机制,包括线粒体功能障碍、内质网应激、蛋白质稳态失调、突触损伤、细胞凋亡和神经炎症。最后,我们研究了目前针对 α-syn 寡聚体的治疗方案。需要进一步研究以了解不同类型寡聚体的结构和毒性机制,为 PD 的治疗提供理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/dcbdb68ee077/ijms-21-08645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/8f0867a0f550/ijms-21-08645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/9b97446be44d/ijms-21-08645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/4e16b5eb5739/ijms-21-08645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/dcbdb68ee077/ijms-21-08645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/8f0867a0f550/ijms-21-08645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/9b97446be44d/ijms-21-08645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/4e16b5eb5739/ijms-21-08645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/7697105/dcbdb68ee077/ijms-21-08645-g004.jpg

相似文献

1
The Role of α-Synuclein Oligomers in Parkinson's Disease.α-突触核蛋白寡聚体在帕金森病中的作用。
Int J Mol Sci. 2020 Nov 17;21(22):8645. doi: 10.3390/ijms21228645.
2
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.α-突触核蛋白:帕金森病中的病理学、线粒体功能障碍和神经炎症。
Neurobiol Dis. 2018 Jan;109(Pt B):249-257. doi: 10.1016/j.nbd.2017.04.004. Epub 2017 Apr 8.
3
Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.合成的α-突触核蛋白原纤维部分通过诱导型一氧化氮合酶介导的一氧化氮生成导致线粒体损伤和选择性多巴胺能神经变性。
Cell Mol Life Sci. 2017 Aug;74(15):2851-2874. doi: 10.1007/s00018-017-2541-x. Epub 2017 May 22.
4
Role of α-synuclein in neurodegeneration: implications for the pathogenesis of Parkinson's disease.α-突触核蛋白在神经退行性变中的作用:对帕金森病发病机制的启示
Essays Biochem. 2014;56:125-35. doi: 10.1042/bse0560125.
5
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis.α-突触核蛋白聚集的中间体:对帕金森病发病机制的影响。
Biophys Chem. 2022 Feb;281:106736. doi: 10.1016/j.bpc.2021.106736. Epub 2021 Dec 6.
6
Modulating α-synuclein propagation and decomposition: Implications in Parkinson's disease therapy.调节α-突触核蛋白的传播和分解:对帕金森病治疗的影响。
Ageing Res Rev. 2024 Jul;98:102319. doi: 10.1016/j.arr.2024.102319. Epub 2024 May 6.
7
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.超越α-突触核蛋白转移:帕金森病中的病理学传播。
Trends Mol Med. 2012 May;18(5):248-55. doi: 10.1016/j.molmed.2012.03.002. Epub 2012 Apr 13.
8
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.α-突触核蛋白导致帕金森病中线粒体功能障碍的共同机制。
J Mol Biol. 2023 Jun 15;435(12):167992. doi: 10.1016/j.jmb.2023.167992. Epub 2023 Feb 2.
9
Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.代谢型谷氨酸受体 5 抑制 α-突触核蛋白诱导的小胶质细胞炎症,从而保护帕金森病的神经毒性。
J Neuroinflammation. 2021 Jan 18;18(1):23. doi: 10.1186/s12974-021-02079-1.
10
Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.家族性帕金森病相关突变对α-突触核蛋白结构及聚集状态的影响
Curr Protein Pept Sci. 2017;18(7):656-676. doi: 10.2174/1389203717666160314151706.

引用本文的文献

1
Protective effects of paederoside in rotenone-induced cellular models of Parkinson's disease.车叶草苷在鱼藤酮诱导的帕金森病细胞模型中的保护作用。
Front Cell Dev Biol. 2025 Aug 7;13:1631652. doi: 10.3389/fcell.2025.1631652. eCollection 2025.
2
Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson's disease and related disorders.神经元中趋化因子表达降低以及内皮细胞中趋化因子表达增加与帕金森病及相关疾病中的神经炎症有关。
Front Cell Neurosci. 2025 Aug 6;19:1557645. doi: 10.3389/fncel.2025.1557645. eCollection 2025.
3
GM1 Oligosaccharide Modulates Microglial Activation and α-Synuclein Clearance in a Human In Vitro Model.

本文引用的文献

1
Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.曲朵司琼通过一种通用机制将错误折叠的蛋白寡聚物从细胞膜上置换下来,并消除其细胞毒性。
Commun Biol. 2020 Aug 13;3(1):435. doi: 10.1038/s42003-020-01140-8.
2
Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.小胶质细胞外泌体促进帕金森病中α-突触核蛋白的传播。
Brain. 2020 May 1;143(5):1476-1497. doi: 10.1093/brain/awaa090.
3
Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation.
GM1寡糖在人源体外模型中调节小胶质细胞激活及α-突触核蛋白清除
Int J Mol Sci. 2025 Aug 7;26(15):7634. doi: 10.3390/ijms26157634.
4
Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis.揭示甲状腺素运载蛋白的众多生理作用:治疗甲状腺素运载蛋白淀粉样变性的关键考量因素
Ann Med. 2025 Dec;57(1):2536755. doi: 10.1080/07853890.2025.2536755. Epub 2025 Jul 27.
5
Epigenome Engineering Using dCas Systems for Biomedical Applications and Biotechnology: Current Achievements, Opportunities and Challenges.利用dCas系统进行生物医学应用和生物技术的表观基因组工程:当前成果、机遇与挑战
Int J Mol Sci. 2025 Jul 2;26(13):6371. doi: 10.3390/ijms26136371.
6
Aberrant phase separation of two PKA RIβ neurological disorder mutants leads to mechanistically distinct signaling deficits.两种蛋白激酶A RIβ神经障碍突变体的异常相分离导致机制上截然不同的信号缺陷。
Cell Rep. 2025 Jun 24;44(6):115797. doi: 10.1016/j.celrep.2025.115797. Epub 2025 Jun 11.
7
Caloric Restriction Mimetics as Priming Agents of Mesenchymal Stem Cells Secretome to Enhance Regenerative Responses to Parkinson's Disease.热量限制模拟物作为间充质干细胞分泌组的启动剂,以增强对帕金森病的再生反应。
Molecules. 2025 May 22;30(11):2260. doi: 10.3390/molecules30112260.
8
Decoding crosstalk between neurotransmitters and α-synuclein in Parkinson's disease: pathogenesis and therapeutic implications.解读帕金森病中神经递质与α-突触核蛋白之间的串扰:发病机制及治疗意义
Ther Adv Neurol Disord. 2025 Jun 5;18:17562864251339895. doi: 10.1177/17562864251339895. eCollection 2025.
9
Intervention strategies for Parkinson's disease: the role of exercise and mitochondria.帕金森病的干预策略:运动与线粒体的作用
Front Aging Neurosci. 2025 May 14;17:1519672. doi: 10.3389/fnagi.2025.1519672. eCollection 2025.
10
Monomers, Dimers, and Oligomers of Pyroglutamate-Modified α-Synuclein Fragments Exhibit Distinct Biophysical Characteristics.焦谷氨酸修饰的α-突触核蛋白片段的单体、二聚体和寡聚体表现出不同的生物物理特性。
ACS Chem Neurosci. 2025 May 21;16(10):1919-1936. doi: 10.1021/acschemneuro.5c00106. Epub 2025 Apr 30.
α-突触核蛋白聚集驱动铁死亡:铁、钙和脂质过氧化作用的相互作用。
Cell Death Differ. 2020 Oct;27(10):2781-2796. doi: 10.1038/s41418-020-0542-z. Epub 2020 Apr 27.
4
Protein transmission in neurodegenerative disease.蛋白质在神经退行性疾病中的传递。
Nat Rev Neurol. 2020 Apr;16(4):199-212. doi: 10.1038/s41582-020-0333-7. Epub 2020 Mar 23.
5
Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.α-突触核蛋白导致多巴胺能神经元中泛素蛋白酶体系统的早期损伤。
Acta Neuropathol Commun. 2020 Feb 14;8(1):17. doi: 10.1186/s40478-020-0894-0.
6
In Vivo Protein Complementation Demonstrates Presynaptic α-Synuclein Oligomerization and Age-Dependent Accumulation of 8-16-mer Oligomer Species.在体蛋白互补实验证明了突触前α-突触核蛋白寡聚体的形成和 8-16 聚体寡聚物物种的年龄依赖性积累。
Cell Rep. 2019 Nov 26;29(9):2862-2874.e9. doi: 10.1016/j.celrep.2019.10.089.
7
Hsp110 mitigates α-synuclein pathology in vivo.Hsp110 减轻体内 α-突触核蛋白病变。
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24310-24316. doi: 10.1073/pnas.1903268116. Epub 2019 Nov 4.
8
Progress of immunotherapy of anti-α-synuclein in Parkinson's disease.帕金森病抗α-突触核蛋白免疫治疗的研究进展。
Biomed Pharmacother. 2019 Jul;115:108843. doi: 10.1016/j.biopha.2019.108843. Epub 2019 May 2.
9
Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes.α-突触核蛋白寡聚物与 Cx32 的结合促进神经元和少突胶质细胞中的蛋白摄取和转移。
Acta Neuropathol. 2019 Jul;138(1):23-47. doi: 10.1007/s00401-019-02007-x. Epub 2019 Apr 11.
10
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.α-突触核蛋白靶向 GluN2A NMDA 受体亚基导致纹状体突触功能障碍和视觉空间记忆改变。
Brain. 2019 May 1;142(5):1365-1385. doi: 10.1093/brain/awz065.